A team from Covington & Burling in Washington represented the pharmaceutical giant GlaxoSmithKline in a record-setting $3 billion criminal and civil settlement over drug misbranding.
July 03, 2012 at 12:00 AM
1 minute read
A team from Covington & Burling in Washington represented the pharmaceutical giant GlaxoSmithKline in a record-setting $3 billion criminal and civil settlement over drug misbranding.
Deputy Attorney General James Cole announced the deal Monday at the U.S. Justice Department, calling it “unprecedented in both size and scope.” No executive was charged Monday.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
The premier educational and networking event for employee benefits brokers and agents.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
